Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 8
1976 15
1977 22
1978 13
1979 12
1980 5
1981 2
1982 4
1983 5
1984 4
1985 5
1986 4
1987 4
1988 10
1989 14
1990 26
1991 33
1992 33
1993 34
1994 42
1995 24
1996 27
1997 15
1998 10
1999 16
2000 20
2001 19
2002 14
2003 12
2004 15
2005 14
2006 12
2007 12
2008 13
2009 26
2010 18
2011 21
2012 22
2013 22
2014 25
2015 26
2016 20
2017 33
2018 30
2019 29
2020 26
2021 16
2022 12
2023 17
2024 24
2025 27
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

870 results

Results by year

Filters applied: . Clear all
Page 1
Cell-Free DNA and Active Rejection in Kidney Allografts.
Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, Matas AJ, Mehta S, Mannon RB, Sharfuddin A, Fischbach B, Narayanan M, Jordan SC, Cohen D, Weir MR, Hiller D, Prasad P, Woodward RN, Grskovic M, Sninsky JJ, Yee JP, Brennan DC; Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study Investigators. Bloom RD, et al. Among authors: matas aj. J Am Soc Nephrol. 2017 Jul;28(7):2221-2232. doi: 10.1681/ASN.2016091034. Epub 2017 Mar 9. J Am Soc Nephrol. 2017. PMID: 28280140 Free PMC article.
Belatacept Pharmacokinetic Analysis of Belatacept Early Steroid Withdrawal Trial (BEST) to Clinical Outcomes and Compared With Reported BENEFIT and BENEFIT-EXT Pharmacokinetic Analysis.
Pyatt A, McGowan M, Tanaka R, Miyagawa B, Mizuno T, Shields AR, Christianson A, West-Thielke P, Leone JP, Woodle ES, Kaufman D, Wiseman A, Matas AJ, Vinks AA, Alloway RR. Pyatt A, et al. Among authors: matas aj. Clin Transplant. 2025 Aug;39(8):e70172. doi: 10.1111/ctr.70172. Clin Transplant. 2025. PMID: 40704545 Clinical Trial.
Living donation: the global perspective.
Matas AJ, Delmonico FL. Matas AJ, et al. Adv Chronic Kidney Dis. 2012 Jul;19(4):269-75. doi: 10.1053/j.ackd.2012.05.003. Adv Chronic Kidney Dis. 2012. PMID: 22732048 Review.
Organ Donation After Euthanasia.
Matas AJ, Payne WD. Matas AJ, et al. JAMA Surg. 2020 Oct 1;155(10):924-925. doi: 10.1001/jamasurg.2020.2514. JAMA Surg. 2020. PMID: 32756887 No abstract available.
Long-term Medical Outcomes of Living Kidney Donors.
Matas AJ, Rule AD. Matas AJ, et al. Mayo Clin Proc. 2022 Nov;97(11):2107-2122. doi: 10.1016/j.mayocp.2022.06.013. Epub 2022 Oct 7. Mayo Clin Proc. 2022. PMID: 36216599 Free PMC article. Review.
The End Kidney Deaths Act.
Perlman E, Ambagtsheer F, Matas A. Perlman E, et al. Among authors: matas a. JAMA. 2025 Aug 26;334(8):735. doi: 10.1001/jama.2025.8240. JAMA. 2025. PMID: 40690230 No abstract available.
Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.
Truchot A, Raynaud M, Helanterä I, Aubert O, Kamar N, Divard G, Astor B, Legendre C, Hertig A, Buchler M, Crespo M, Akalin E, Pujol GS, Ribeiro de Castro MC, Matas AJ, Ulloa C, Jordan SC, Huang E, Juric I, Basic-Jukic N, Coemans M, Naesens M, Friedewald JJ, Silva HT Jr, Lefaucheur C, Segev DL, Collins GS, Loupy A. Truchot A, et al. Among authors: matas aj. J Am Soc Nephrol. 2025 Apr 1;36(4):688-701. doi: 10.1681/ASN.0000000517. Epub 2024 Oct 16. J Am Soc Nephrol. 2025. PMID: 40168162 Free PMC article.
870 results